We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2011 by Mohamed Saied Eldin Elsafty, Ain Shams University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01496105
First Posted: December 21, 2011
Last Update Posted: December 21, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Mohamed Saied Eldin Elsafty, Ain Shams University
December 13, 2011
December 21, 2011
December 21, 2011
July 2011
December 2011   (Final data collection date for primary outcome measure)
VAS score of Pain [ Time Frame: 5 minutes from lidocaine spraying ( after application of tenaculum) ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion
Not Provided
The purpose of this study is to determine whether the topical use of lidocaine spray 10% on the cervix is an effective way to reduce pain during IUCD insertion.
Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Prevention
Drug Usage
  • Drug: Lidocaine
  • Drug: saline
  • Active Comparator: lidocaine spray 10%
    Intervention: Drug: Lidocaine
  • Placebo Comparator: Saline
    Intervention: Drug: saline
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
200
January 2012
December 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18-45
  • Speak Arabic or English

Exclusion Criteria:

  • History of cervical surgery
  • Known hypersensitivity to topical analgesics
  • First trimester abortion or miscarriage in the previous six weeks
  • Second trimester abortion or miscarriage in the previous 12 weeks
Sexes Eligible for Study: Female
18 Years to 45 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Egypt
 
 
NCT01496105
ali elyan 2011
Yes
Not Provided
Not Provided
Mohamed Saied Eldin Elsafty, Ain Shams University
Ain Shams University
Not Provided
Not Provided
Ain Shams University
December 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP